Skip to main content

Table 2 Response of primary tumor and nodal status*

From: Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer

Response

N (%)

ypT:

 

 0

3 (7.5)

 1

1 (2.5)

 2

12 (30.0)

 3

22 (55.0)

 4

1 (2.5)

 Not available*

1 (2.5)

ypN:

 

 0

25 (62.5)

 1

13 (32.5)

 2

1 (2.5)

 Not available*

1 (2.5)

Tumor regression grade:

 

 1

3 (7.0)

 2

8 (20.0)

 3

19 (47.5)

 4

9 (22.5)

 Not available*

1 (2.5)

  1. *One patient did not undergo surgery.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us